Real-Time email alerts. Get critical information on your stocks.
1 Which stocks are you watching?
 2 Where to send your updates?

Aceto Corporation (ACET) Stock Quote

Detailed Quote for Aceto Corporation (ACET) 
$ 11.86   0.30 (+2.60%) Volume: 243.4 k 4:23 PM EDT May 20, 2013
Today 5d 1m 3m 1y more
Last Price
11.86
Change $
0.30
Change %
2.60%
Tick
N/A
Bid
8.50
Bid Size
200
Ask
12.17
Ask Size
100
Open
11.54
High
12.08
Low
11.50
Prev Close
11.56
Last Trade
05/20/13
Volume
243.4 k
52 Wk Hi
12.08
52 Wk Low
7.9001
Market Cap
324.89 m
Ex-Div Date
06/12/13
Div Rate
0.22
Yield
1.855
Shares
27,393,375
EPS (TTM)
0.69
PE Ratio
14.90
Exchange
NGS
News and Media for Aceto Corporation  (ACET) 
Sector News | Topic News
News for ACET
Thu, May 09, 2013
5:05 PM ACETO Board of Directors Declares Quarterly Cash Dividend - Globe Newswire
5:00 PM ACETO Reports Record Fiscal 2013 Third Quarter Net Sales and Gross Profit - Globe Newswire
Fri, Apr 26, 2013
6:59 AM ACETO Corporation Schedules Fiscal 2013 Third Quarter Financial Results News Release and Conference Call - Globe Newswire
Wed, Apr 24, 2013
9:00 AM ACETO Announces Management Transition at Its Rising Pharmaceuticals Subsidiary - Globe Newswire
Thu, Feb 07, 2013
5:09 PM ACETO Reports Fiscal 2013 Second Quarter Results - Globe Newswire
1:26 PM ACETO Board of Directors Declares Quarterly Cash Dividend - Globe Newswire
Thu, Jan 24, 2013
6:59 AM ACETO Corporation Schedules Fiscal 2013 Second Quarter Financial Results News Release and Conference Call - Globe Newswire
Tue, Dec 11, 2012
6:59 AM ACETO Subsidiary, Rising Pharmaceuticals, Launches First Generic Version of Grifulvin V(R) - Globe Newswire
Thu, Dec 06, 2012
1:30 PM ACETO Board of Directors Declares Quarterly Cash Dividend - Globe Newswire
Wed, Nov 28, 2012
10:15 AM ACETO to Present at the Oppenheimer 23rd Annual Healthcare Conference - Globe Newswire
Mon, Nov 26, 2012
9:48 AM ACETO Subsidiary, Rising Pharmaceuticals, to Launch Generic Version of Cleocin Pediatric(R) - Globe Newswire
Mon, Nov 19, 2012
10:20 AM ACETO Subsidiary, Rising Pharmaceuticals, to Launch First Generic Version of Gris-PEG(R) - Globe Newswire
Thu, Nov 08, 2012
5:00 PM ACETO Reports Fiscal 2013 First Quarter Results - Globe Newswire
Fri, Nov 02, 2012
6:59 AM ACETO Subsidiary, Rising Pharmaceuticals, Announces the Signing of Their First Agreement to Market an Authorized Generic Drug (Parnate(R) Product) With Covis Pharma S.a.r.l. - Globe Newswire
Thu, Oct 25, 2012
6:59 AM ACETO Corporation Schedules Fiscal 2013 First Quarter Financial Results News Release and Conference Call - Globe Newswire
Tue, Oct 23, 2012
6:59 AM ACETO to Present at the Singular Research 7th Annual Best of the Uncovereds - Globe Newswire
Fri, Sep 07, 2012
6:59 AM ACETO Outlines CEO Succession Plan - Globe Newswire
Thu, Sep 06, 2012
5:00 PM ACETO Announces Fiscal 2012 Fourth Quarter and Year End Results - Globe Newswire
Thu, Aug 23, 2012
6:59 AM ACETO Corporation Schedules Fiscal 2012 Year Ending and Fourth Quarter Financial Results News Release and Conference Call - Globe Newswire
Wed, Jul 25, 2012
8:00 AM Plandai Biotech (OTCBB: PLPL) Moves Towards Initial Production - Marketwired
More News for ACET >>

Tags for Aceto Corporation

Research stocks or mutual funds related to Aceto Corporation by keywords or tags. Find companies that have a similar focus to ACET. The keywords below have been associated to ACET by either user submission or electronic means.

creating customer value mumbai stock exchanges in india pharmaceutical gmp radisson sas hotel hamburg customer acquisition financial plans european corporate governance corporate financial planning customer retention corporate governance quotient And Organic Dyes And Pig (2865) pharmaceutical market corporate governance consulting corporate governance training pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics model customer service pharmaceutical automation niche pharmaceutical stock information Chemicals customer attrition pharmaceutical research and development financial statements annual report pharmaceutical manufacturing company aceto improve customer service pharma marketing corporate governance pharma supply chain annual report photography contract agreements pharmaceutical software pharmaceutical quality control corporate governance practices identity audit customer service automation pharma license pharmaceutical supply chain pharmaceuticals supply chain financial report corporate governance issues customer relationships tax audit cell phone number reverse lookup corporate governance ratings annual report printing

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.